Literature DB >> 6324597

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.

P W Gold, G Chrousos, C Kellner, R Post, A Roy, P Augerinos, H Schulte, E Oldfield, D L Loriaux.   

Abstract

Corticotropin-releasing factor (CRF) is a newly sequenced neuropeptide thought to be a principal stimulus to pituitary corticotropin (ACTH) secretion. Evidence obtained from laboratory animals and primates is reviewed which indicates that CRF not only stimulates the pituitary-adrenal axis but also influences several aspects of CNS function which may be of relevance to psychiatric illness. Clinically, experience in administering ovine CRF to more than 150 individuals shows that CRF can be helpful in resolving differential diagnostic dilemmas in patients with various disorders of the hypothalamic-pituitary-adrenal axis and in furthering an understanding of the pathophysiology of conditions such as Cushing's disease and depression.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324597     DOI: 10.1176/ajp.141.5.619

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  29 in total

1.  Innervation of the zona fasciculata of the adult human adrenal cortex: a light and electron microscopic study.

Authors:  K Dorovini-Zis; A P Zis
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 2.  Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

Authors:  M Nink; U Krause; H Lehnert; J Beyer
Journal:  Klin Wochenschr       Date:  1991-03-18

Review 3.  [New insights into the pathogenesis and pathophysiology of depression].

Authors:  C Schüle; T C Baghai; R Rupprecht
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

4.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

5.  Hormones and behaviour: discussion paper.

Authors:  B T Donovan
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

6.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 7.  [Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction].

Authors:  Marcelo F Mello; Alvaro A Faria; Andrea F Mello; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Braz J Psychiatry       Date:  2009-10       Impact factor: 2.697

8.  Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.

Authors:  Aju Abraham; Stuart Watson; Allan H Young
Journal:  Indian J Psychiatry       Date:  2003-04       Impact factor: 1.759

Review 9.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

10.  The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.

Authors:  Cornelius Schüle; Thomas C Baghai; Daniela Eser; Sibylle Häfner; Christoph Born; Sascha Herrmann; Rainer Rupprecht
Journal:  PLoS One       Date:  2009-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.